Apyx Medical Corporation

NASDAQ: APYX · Real-Time Price · USD
2.14
0.02 (0.94%)
At close: Aug 15, 2025, 3:06 PM

Apyx Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
11.37M 9.43M 14.22M 11.49M 12.15M 10.24M 14.66M 11.98M 13.57M 12.14M 12.61M 9.11M 10.29M 12.49M 16.82M 11.83M 11.22M 8.64M
Cost of Revenue
4.29M 3.77M 5.26M 4.53M 9.34M 8.59M 10.6M 8M 4.29M 4.57M 4.37M 3.36M 3.38M 4.27M 4.67M 3.77M 3.69M 2.78M
Gross Profit
7.08M 5.67M 8.96M 6.95M 2.81M 10.63M 4.06M 3.31M 9.28M 7.57M 8.24M 5.76M 6.91M 8.22M 12.15M 8.06M 7.53M 5.86M
Operating Income
-2.57M -3.05M -3.05M -3.63M -5.55M -6.62M -5.78M -4.64M -1.24M -5.61M -5.93M -5.78M -5.98M -5.87M -1.69M -3.97M -4.04M -4.75M
Interest Income
278K 304K 294K 378K 439K 495K 443K 248K 179K 51K 64K 73K 18K 2K 2K 2K 4K 3K
Pretax Income
-3.69M -4.12M -4.57M -4.66M -6.54M -7.54M -9.54M -4.99M -953K -5.8M -5.91M -5.75M -5.35M -5.9M -1.88M -4.16M -3.94M -4.84M
Net Income
-3.78M -4.15M -4.63M -4.7M -6.56M -7.58M -9.61M -4.63M -994K -3.53M -6.05M -5.79M -5.45M -5.97M -2M -4.22M -4.05M -4.9M
Selling & General & Admin
4.14M 3.38M 10.89M 9.45M 6.93M 4.9M 8.59M 4.84M 12.01M 12.06M 12.92M 10.48M 11.82M 12.93M 12.9M 10.85M 10.49M 9.49M
Research & Development
824K 804K 1.12M 1.14M 1.42M 1.4M 1.25M 1.28M 1.2M 1.12M 1.25M 1.06M 1.07M 1.16M 947K 1.18M 1.08M 1.11M
Other Expenses
403K 4.53M n/a n/a n/a 10.95M n/a 1.83M n/a -5K n/a -35K n/a -21K n/a n/a 97K -93K
Operating Expenses
5.37M 8.72M 12.01M 10.59M 8.36M 17.25M 9.84M 7.95M 13.21M 13.18M 14.17M 11.54M 12.89M 14.09M 13.84M 12.02M 11.58M 10.61M
Interest Expense
1.39M -1.38M 1.65M 1.43M 1.43M 1.4M 1.12M 585K 543K 234K 3K 1K 3K 8K 1K 3K 2K 4K
Selling & Marketing Expenses
n/a n/a n/a n/a -4.68M -6.27M -4.87M -6.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.95M 12.48M 17.27M 15.12M 17.7M 16.86M 20.44M 16.61M 17.5M 17.75M 18.54M 14.9M 16.27M 18.36M 18.52M 15.8M 15.27M 13.38M
Income Tax Expense
49K 49K 89K 60K 50K 53K 87K -318K 66K -2.27M 151K 50K 96K 70K 134K 73K 107K 66K
Shares Outstanding (Basic)
40.73M 35.54M 38.22M 34.64M 34.64M 34.64M 34.64M 34.64M 34.6M 34.6M 34.6M 34.57M 34.46M 34.43M 34.37M 34.33M 33.72M 34.3M
Shares Outstanding (Diluted)
40.73M 35.54M 38.22M 34.64M 34.64M 34.64M 34.64M 34.64M 34.6M 34.6M 34.6M 34.57M 34.46M 34.43M 34.37M 34.33M 34.32M 34.3M
EPS (Basic)
-0.09 -0.12 -0.12 -0.14 -0.19 -0.22 -0.28 -0.13 -0.03 -0.1 -0.17 -0.17 -0.16 -0.17 -0.06 -0.12 -0.12 -0.14
EPS (Diluted)
-0.09 -0.12 -0.12 -0.14 -0.19 -0.22 -0.28 -0.13 -0.03 -0.1 -0.17 -0.17 -0.16 -0.17 -0.06 -0.12 -0.12 -0.14
EBITDA
-2.57M -3.05M -2.77M -3.09M -4.95M -5.98M -8.27M -4.22M -259K -5.36M -5.71M -5.53M -5.1M -5.67M -1.65M -3.92M -3.73M -4.61M
EBIT
-2.3M -2.75M -2.92M -3.23M -5.11M -6.14M -8.42M -4.41M -410K -5.57M -5.91M -5.74M -5.35M -5.89M -1.88M -4.16M -3.94M -4.83M
Depreciation & Amortization
n/a 138K 142K 144K 156K 157K 152K 186K 151K 203K 202K 216K 247K 225K 229K 234K 213K 227K